The chemical class designated as Rhox13 Activators encompasses a diverse group of molecules known to modulate gene expression through various mechanisms that can influence the activity of the Rhox13 protein. These activators typically affect the transcriptional machinery or the epigenetic landscape, thereby facilitating the expression of Rhox13. These compounds generally achieve this by interacting with cellular components that are upstream regulators of gene expression. Some members of this class function by inhibiting enzymes responsible for adding methyl groups to DNA, leading to a reduction in DNA methylation levels. This decrease in methylation can activate transcription by enabling transcription factors and other regulatory proteins to access the DNA more readily. Others in this group work by inhibiting histone deacetylases (HDACs), which leads to a more open chromatin structure and, consequently, an increase in gene expression.
Additionally, activators within this class can also act through signal transduction pathways to modulate gene expression indirectly. They can alter intracellular signaling cascades, such as those involving cyclic AMP (cAMP) or protein kinase A (PKA), which can result in the activation of transcription factors that target the Rhox13 gene. The modulation of these pathways can lead to changes in the transcriptional activity of Rhox13, among other genes. The activators can also influence other cellular processes related to gene expression, such as cellular differentiation, where they can encourage the expression of genes necessary for the development and function of reproductive tissues. Through these various mechanisms, Rhox13 Activators can play a significant role in the regulation of gene expression and provide insights into the molecular control of reproductive processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid regulates gene expression through retinoic acid receptors, which could possibly activate Rhox13 by promoting transcription of homeobox gene family members. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor could possibly activate Rhox13 by inducing chromatin remodeling, facilitating access of transcription machinery to the gene. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
As a cAMP analog, Dibutyryl cAMP could possibly activate Rhox13 by mimicking the effect of cAMP and enhancing transcription of cAMP-responsive genes. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, could possibly activate Rhox13 by increasing gene expression through altering chromatin structure. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG could possibly activate Rhox13 by affecting DNA methylation and histone modification states, potentially leading to gene expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane could possibly activate Rhox13 by influencing histone acetylation and methylation, potentially creating a favorable state for gene expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, as an isoflavone, could possibly activate Rhox13 by influencing kinase signaling and gene regulation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
This inhibitor could possibly activate Rhox13 by inhibiting DNA methyltransferases, potentially leading to upregulation of the gene. | ||||||
Kinetin | 525-79-1 | sc-207780 sc-207780A | 1 g 5 g | $38.00 $48.00 | ||
Kinetin could possibly activate Rhox13 by affecting cellular differentiation processes that involve the regulation of developmental genes. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine, a DNA methyltransferase inhibitor, could possibly activate Rhox13 by leading to gene demethylation, which may result in an environment conducive to gene expression. | ||||||